LAUER REGAN J 4
4 · ImmunityBio, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
LAUER REGAN J
Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2024-01-31$3.36/sh−13,470$45,259→ 94,334 total - Exercise/Conversion
Common Stock
2024-01-31+32,872→ 107,804 total - Exercise/Conversion
Restricted Stock Units
2024-01-31−32,872→ 0 total→ Common Stock (32,872 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
- [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, fifty percent (50%) of the RSUs subject to the award vested on September 1, 2023 and the remaining fifty percent (50%) of the RSUs subject to the award vested on January 31, 2024.